Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-003572-36Phase 2Terminated
Phase 2, randomised, open-label trial of liraglutide in stroke (2 arms), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoints: Feasibility of definitive trial processes, Recruitment of target sample and 1 more. Started Dec 2011; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-003572-36.